Greenwood Highlights Role of Innovation in Solving Opioid Crisis

BIOtech Now
Andrew Segerman

The numbers are staggering. The opioid epidemic is costing our nation more than $500 billion annually in health and social costs. What’s more, 1 in 5 deaths among young adults in 2016 were opioid related. This crisis is plaguing communities across the country, leaving in its wake countless victims, devastated families and economic ruin.

Jim Greenwood, BIO’s President and CEO, has been on the air describing for radio listeners across the country the urgent need to spur access to, and greater innovation of, novel therapies to help treat both pain and addiction.

Don’t miss Jim’s recent radio interviews:

And for more information about the biopharmaceutical industry’s commitment to combating the opioid crisis, please visit

Full BIOtech Now Article here

Powered by WPeMatico